AMG 595 First-in-Human in Recurrent Gliomas
Clinical trial NCT01475006 · COMPLETED
Trial details
- NCT number
- NCT01475006
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.